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Abstract
Objective: To investigate a 24-hour glycemic variation in drug-naı¨ve, type 2 diabetic patients by using CGM.
Methods: A total of 30 inpatients with type 2 diabetes were included in the study to analyze the 24-hour CGM data.
Results: The patients’ median age was 58 years old (interquartile range: 42–66 years), and their median HbA1c value was 7.6
(6.7–8.8)%. The median time to postprandial peak glucose levels(Peak Time) for each meal was 70–85 minutes, with the
range of postprandial glucose increases(Increase Range) for each meal being 83–109 mg/dL. There was a significant positive
correlation between the HbA1c values and Increases Range, Peak Time observed after breakfast and dinner, respectively.
When the patients were stratified by a median HbA1c value of 7.6% into 2 groups, Increases Range and Peak Time, after
breakfast, were shown to be significantly higher in the high-HbA1c group (H) than in the low-HbA1c (L) group. When the
subjects were divided into four groups according to HbA1c levels:1 (,7.0%, n = 8), 2 (7.0–7.9%, n = 8), 3 (8.0–8.9%, n = 8),
and 4 ($9%, n = 6), the average glucose level, pre-meal glucose level and postprandial peak glucose level increased steadily
from group 1 to 4 in a stepwise manner.
Conclusions: In drug-naı¨ve, Japanese type 2 diabetic patients, the Peak Time and the Increase Range were maximal after
dinner. It was shown that the greater the HbA1c values, the longer Peak time and the higher Increase Range after breakfast
and dinner. The average glucose level, pre meal glucose level and postprandial peak glucose level increased steadily as
HbA1c level increased.
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Introduction
In recent years, improving postprandial hyperglycemia has been
shown to play an important role in preventing cardiovascular
events [1–4]. One of the angiopathic mechanisms due to
postprandial hyperglycemia includes contribution of the oxidative
stress. Monnier et al reported that oxidative stress showed Mean
Amplitude of Glycemic Excursions (MAGE: measure of diabetic
instability) and postprandial blood glucose elevation and a strong
positive correlation [5]. Facilitating control of such glucose
excursions requires an in-depth understanding of postprandial
glucose variations.
However, there are very few studies published to date that
investigated postprandial glucose variations in type 2 diabetic
patients in depth by using CGM [6,7].
Besides, these studies included a large number of patients who
were receiving oral hypoglycemic agents, which could influence
the parameters for glycemic variations, such as time to postpran-
dial glucose peaks or the range of postprandial glucose increases,
making it rather difficult to evaluate the status of postprandial
glycemic variations in type 2 diabetic patients as it is.
Thus, it is important to have an accurate grasp of glycemic
variations in type 2 diabetic patients who are not receiving any
anti-diabetic drugs. However, to the best of our knowledge, to
date, no study has been reported in which this has been addressed.
Therefore, our present study aimed to give a full picture of
glycemic variations in type 2 diabetic patients.
Patients and Methods
A total of 30 inpatients with drug-naı¨ve type 2 diabetes were
included in this study to analyze the continuous 24-hour CGM
data obtained without measurement errors immediately after
placement of the CGM sensors. Of all type 2 diabetic patients
admitted for glycemic control and monitored by CGM between
January 2007 and January 2012, all eligible patients were enrolled
in the study. For CGM, CGMS System Gold (Medtronic Inc) was
used, with its sensor attached to the abdomen in each subject, who
was instructed to refrain from excessive exercises and between-
meal eating and to live as much as usual during CGM monitoring.
The total amount of energy to be taken through meals was
determined by using 25–30 kcal/kg as a reference, and the
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patients were given meals that accounted for 1,440 kcal/day,
1,600 kcal/day and 1,840 kcal/day. In terms of monthly
averages, breakfast accounted for 435 kcal (carbohydrates,
50.3%; proteins, 14.8%; and lipids, 35.0%), 508 kcal (carbo-
hydrates, 51.8%; proteins, 14.5%; and lipids, 33.8%), or
539 kcal (carbohydrates, 48.5%; proteins, 14.5%; and lipids,
37.0%) at 8 am; lunch accounted for 491 kcal (carbohydrates,
61.6%; proteins, 19.4%; and lipids, 19.1%), 545 kcal (carbo-
hydrates, 63.3%; proteins, 18.0%; and lipids, 18.6%), or
654 kcal (carbohydrates, 60.7%; proteins, 17.6%; and lipids,
21.7%) at noon; and dinner accounted for 513 kcal (carbohy-
drates, 62.2%; proteins, 19.0%; and lipids, 18.9%), 548 kcal
(carbohydrates, 64.4%; proteins, 18.4%; and lipids, 17.2%), or
647 kcal (carbohydrates, 61.4%; proteins, 17.1%; and lipids,
21.5%) at 6 pm.
All subjects were instructed to restrict their exercise to the level
to which it is usually practiced. A majority of patients were found
to have taken 30-minute strolls once or twice daily in the premises.
Breakfast, lunch and dinner were provided daily at 8:00, 12:00,
and 18:00, respectively.
Parameters to be evaluated in CGM included 24-hour mean
glucose levels, standard deviations (SD) of 24-hour glucose levels,
MAGE, pre-meal glucose level, postprandial peak glucose level,
the range of postprandial glucose increases from premeal, and
times to glucose peaks after each meal. To minimize the influence
of hospital admission, CGM data obtained in the first 24 hours
after admission were used to calculate the SD of 24-hour glucose
levels and the MAGE for analysis in principle.
The HbA1c values and the range of glucose increases after each
meal from premeal, as well as the HbA1c values and the times to
glucose peaks after each meal, were examined for correlation. The
HbA1c values used for analysis in this study were those obtained at
admission.
The patient population in this study was associated with a
median HbA1c value of 7.6%, and the patients were stratified by
the median HbA1c levels. The glucose profiles between the groups
were compared.
Then the subjects were divided into four groups according to
HbA1c levels:1 (,7.0%, n = 8), 2 (7.0–7.9%, n = 8), 3 (8.0–8.9%,
n = 8), and 4 ($9%, n = 6) to examine each parameter related to
glycemic variations to identify trends, if any, for each HbA1c
stratum.
Statistical analyses were performed by using SPSS Ver. 17.
Values for all parameters are represented as medians (interquartile
range, 25% to 75%) and were compared by using Kruskal-Wallis
test and Mann-Whitney test. Spearman’s correlation coefficients
were used to examine correlation between any 2 variables.
Written informed consent was obtained from participants of this
study. The present study was conducted with the approval of the
Ethics Committee of Jikei University School of Medicine, Tokyo,
Japan.
Results
Of the 30 patients included in the study, 22 were males and 8
were females. Their median age was 58 (interquartile range, 42–
66) years; their median BMI, 25.3 (22.6–27.3) kg/m2; their
median HbA1c, 7.6 (6.7–8.8) %; and their median urinary C
peptide immunoreactivity (CPR), 78.6 (60.7–99.8) mg/day. Their
median glucose level was 137 (117–179) mg/dL; their SD, 32.5
(26.8–48.5); their median MAGE, 90.8 (75.9–120.3); their highest
median glucose level, 218 (188–315) mg/dL; and their lowest
median glucose level, 83 (74–119) mg/dL; their median pre-meal
glucose level, breakfast 121 (103–149) mg/dL, lunch 109 (96–146)
mg/dL, dinner 109 (91–148) mg/dL; their median postprandial
peak glucose level, breakfast 205 (172–267), lunch 200 (167–265),
dinner 217 (173–280). (Table 1, Figure 1).
The median range of glucose increases from premeal was 83
(59–119) mg/dL after breakfast, 84 (66–106) mg/dL after lunch,
and 109 (84–120) mg/dL after dinner.
The median time to glucose peaks in the patients was 83 (59–
110) minutes after breakfast, 70 (59–88) minutes after lunch, and
85 (65–99) minutes after dinner.
The correlation coefficients (r) for the HbA1c values and the
range of postprandial glucose increases were shown to be 0.421
(P = 0.021) after breakfast, 0.020 (P = 0.916) after lunch, and 0.456
after dinner (P = 0.011), demonstrating a significant positive
correlation between the HbA1c values and the range of
postprandial increases from premeal after breakfast and dinner.
The correlation coefficients (r) for the HbA1c values and the
time to postprandial glucose peaks were shown to be 0.673
(P,0.0001) after breakfast, 20.169 (P = 0.373) after lunch, and
0.487 after dinner (P = 0.006), demonstrating a significant positive
correlation between the HbA1c values and the time to postpran-
dial glucose peaks after breakfast and dinner. (Figure 2).
Then, by using the median HbA1c value 7.6%, the patients
were stratified into 2 groups, i.e., those with HbA1c 5.7 to 7.3%
(low-HbA1c group) (n = 15) and those with HbA1c 7.8 to 12.6%
(high-HbA1c group) (n = 15). The median HbA1c value was 6.8
Figure 1. 24-hour glycemic variations drug-naı¨ve, type 2
diabetic patients. A) All patients (n = 30). B) Low-HbA1c group
(n = 15) and high-HbA1c group (n = 15), Low-HbA1c group: HbA1c 5.7–
7.3%, High-HbA1c group: HbA1c 7.8–12.6%. C) Four groups according
to HbA1c levels:1 (,7.0%, n= 8), 2 (7.0–7.9%, n = 8), 3 (8.0–8.9%, n = 8),
and 4 ($9%, n= 6).
doi:10.1371/journal.pone.0071102.g001
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(6.1–7.1)% in the low-HbA1c group and 8.8 (8.1–9.5)% in the
high-HbA1c group.
Again, the median of the average glucose level was 119 (112–
134) mg/dL in the low-HbA1c group and 177 (142–233) mg/dL
in the high-HbA1c group (P = 0.001); their median SD, 30 (24–36)
mg/dL in the low-HbA1c group and 47 (30–54) mg/dL
(P = 0.027) in the high-HbA1c group; their median MAGE, 80.3
(65.0–94.7) in the low-HbA1c group and 105.3 (90.0–124.7) in the
high-HbA1c group (P = 0.010); their median pre-meal glucose
level in the low- and high-HbA1c groups was 112 (97–122) mg/dL
and 139 (119–178) mg/dL before breakfast (P = 0.007), 100 (90–
111) mg/dL and 133 (104–205) mg/dL before lunch (P = 0.008),
and 103 (89–113) mg/dL and 146 (91–175) mg/dL before dinner
(P = 0.056), respectively; their median postprandial peak glucose
level in the low- and high-HbA1c groups was 178 (149–200) mg/
dL and 243 (209–317) mg/dL after breakfast (P = 0.001), 173
(156–207) mg/dL and 242 (192–318) mg/dL after lunch
(P = 0.013), and 186 (154–217) mg/dL and 261 (216–314) mg/
dL after dinner (P = 0.001), respectively. Thus, all these param-
eters were shown to be significantly greater in the high-HbA1c
group than in the low-HbA1c group. (Table 1, Figure 1).
The median range of postprandial glucose increases in the low-
and high-HbA1c groups was shown to be 70 (43–94) mg/dL and
98 (70–143) mg/dL after breakfast (P = 0.017), 84 (56–103) mg/dL
and 84 (73–109) mg/dL after lunch (P = 0.590), and 88 (59–111)
mg/dL and 115 (106–146) mg/dL after dinner (P = 0.005),
respectively, demonstrating that the range of glucose increases
from premeal was significantly greater after breakfast and dinner
in the high-HbA1c group than in the low-HbA1c group.
The median time to postprandial glucose peaks in the low- and
high-HbA1c groups was shown to be 70 (50–80) minutes and 110
(85–125) minutes after breakfast (P = 0.002), 75 (60–95) minutes
and 65 (55–75) minutes after lunch (P = 0.588), and 65 (55–90)
minutes and 90 (80–120) minutes after dinner (P = 0.013),
respectively, showing that the time to postprandial glucose peaks
was significantly longer after breakfast and dinner in the high-
HbA1c group than in the low-HbA1c group.
When the subjects were divided into four groups according to
HbA1c levels, the average glucose level, pre-meal glucose level and
postprandial peak glucose level increased steadily from group 1 to
4 in a stepwise manner. (Table 2, Figure 1).
Table 1. Patient profile and the summary for glycemic variations by the median HbA1c value of 7.6%.
Overall Low-HbA1c group High-HbA1c group P value*
Patients tested(n) 30 15 15
Age(years) 58(42–66) 58(50–67) 57(39–65) 0.852
Sex(male/female) 22/8 8/7 14/1 0.011
Duration of diabetes(years) 1.7(0.3–3.3) 1.0(0.3–3.0) 2.0(0.3–6.0) 0.267
BMI(kg/m2) 25.3(22.6–27.3) 24.0(21.6–27.9) 25.3(23.5–27.3) 0.477
Urinary CPR(mg/day) 78.6(60.7–99.8) 78.0(44.1–98.7) 79.1(70.2–101.0) 0.363
HbA1c(%) 7.6(6.7–8.8) 6.8(6.1–7.1) 8.8(8.1–9.5) ,0.001
Average glucose level(mg/dL) 137(117–179) 119(112–134) 177(142–233) 0.001
SD(mg/dL) 32.5(26.8–48.5) 30(24–36) 47(30–54) 0.027
MAGE(mg/dL) 90.8(75.9–120.3) 80.3(65.0–94.7) 105.3(90.0–124.7) 0.010
Pre-meal glucose level(mg/dL)
Breakfast 121(103–149) 112(97–122) 139(119–178) 0.007
Lunch 109(96–146) 100(90–111) 133(104–205) 0.008
Dinner 109(91–148) 103(91–112) 148(99–171) 0.056
Postprandial peak glucose Level(mg/dL)
Breakfast 205(172–267) 178(149–200) 243(209–317) 0.001
Lunch 200(167–265) 173(156–207) 242(192–318) 0.013
Dinner 217(173–280) 186(154–217) 261(216–314) 0.001
Range of glucose increases from premeal(mg/dL)
Breakfast 83(59–119) 70(43–94) 98(70–143) 0.017
Lunch 84(66–106) 84(56–103) 84(73–109) 0.590
Dinner 109(84–120) 88(59–111) 115(106–146) 0.005
Time to glucose peaks (minutes)
Breakfast 83(59–110) 70(50–80) 110(85–125) 0.002
Lunch 70(59–88) 75(60–95) 65(55–75) 0.588
Dinner 85(65–99) 65(55–90) 90(80–120) 0.013
Abbreviations: CPR, C peptide immunoreactivity; MAGE, mean amplitude of glycemic excursions.
Data are shown as medians (interquartile range: 25 to 75 percentiles).
*Mann-Whitney test for comparisons between the low- and high-HbA1c groups; Fisher’s exact test for sex differences.
Low-HbA1c group: HbA1c 5.7–7.3%, High-HbA1c group: HbA1c 7.8–12.6%.
doi:10.1371/journal.pone.0071102.t001
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The study subjects were stratified by sex into two groups for
analysis, which, however, demonstrated no difference between the
groups with regard to the CGM data.
Discussion
In this study of drug-naı¨ve type 2 diabetic patients with the
median HbA1c 7.6 (6.7–8.8)%, the median of the average glucose
level was shown to be 137 (117–179) mg/dL, with the median of
their SD being 32.5 (26.8–48.5). In our early study of 24 Japanese
subjects with normal glucose tolerance (NGT) [8], the median of
the average glucose level was 101 (96–106) mg/dL, with the
median of their SD being 16.5 (14.0–19.0). The postprandial
glucose peaks were seen in these individuals about 40 to 50
minutes after the start of meals, with the median range of
postprandial glucose increases from premeal being 21 (12–32) mg/
dL after breakfast, 37 (27–48) mg/dL after lunch, and 44 (25–63)
mg/dL after dinner, showing that the range of postprandial
glucose increases from premeal was greatest after dinner, followed
by that after lunch and smallest after breakfast. Of note, in a study
of 434 Chinese subjects with NGT [9], the mean 6 SD for the 24-
hour glucose levels was shown to be 104610 mg/dL with the
mean SD being 14.2, consistently with the values reported for the
Japanese counterparts.
In this study, the range of glucose increases from premeal to
glucose peaks was shown to be 83–109 mg/dL in Japanese type 2
diabetic patients, with the time to postprandial glucose peaks being
70–85 minutes, demonstrating that the range of glucose increases
was about 2- to 4-fold higher and the time to postprandial glucose
peaks was about 20–40 minutes longer in these patients than in the
NGT subjects mentioned above [8].
In contrast, the range of glucose increases from premeal was
greatest after dinner, followed by that after lunch and smallest
after breakfast in these patients, as was the case with the NGT
individuals.
In a study of 131 Caucasian type 2 diabetic patients by Monnier
et al [6], the peak glucose level was shown to be greatest after
breakfast, with the time to postprandial glucose peaks being also
longest after breakfast, in contrast to the CGM data in Japanese
type 2 diabetic patients presented in this study. This disparity may
be accounted for by the fact that the patients in this study were not
receiving oral hypoglycemic agents and that the calorie intake
varied among the meals taken during the study.
In this study, breakfast was designed to be lower in calorie than
lunch or dinner, to obtain data in a setting as close to real life as
possible, by taking into account everyday diet habits in Japan that
prefer quick, low-calorie meals for breakfast, and slow, high-
calorie meals for dinner. It is of note here that the range of glucose
increases from premeal was shown to be greatest after dinner in
our study of Japanese NGT individuals [8], as in our Japanese type
2 diabetic patients.
In a study examining correlation between postprandial glucose
levels, fasting glucose levels and HbA1c values in 290 type 2
diabetic patients [10], Monnier et al reported that the postpran-
dial glucose levels accounted for as much as 70% of the HbA1c
values in those with HbA1c less than 7.3% but no more than 40%
in those with HbA1c over 9.3%, suggesting that, primarily,
restoring the fasting glucose levels to as close to normal as possible
leads to improvements in HbA1c values in those with poorly
controlled disease (HbA1c, 8% or greater), while suppressing
postprandial hyperglycemia leads to improvements in HbA1c
Figure 2. Correlation between the HbA1c and postprandial glucose increases, and time to postprandial glucose peaks. a) Correlation
between the HbA1c values and the range of glucose increases after breakfast from premeal. b) Correlation between the HbA1c values and the range
of glucose increases after lunch from premeal. c) Correlation between the HbA1c values and the range of glucose increases after dinner from
premeal. d) Correlation between the HbA1c values and the time to glucose peaks after breakfast. e) Correlation between the HbA1c values and the
time to glucose peaks after lunch. f) Correlation between the HbA1c values and the time to glucose peaks after dinner. Spearman’s correlation
coefficients were used to examine correlation between any 2 variables.
doi:10.1371/journal.pone.0071102.g002
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values in those with relatively well controlled disease (HbA1c,
about 7%) who are less associated with increases in fasting glucose
levels.
Again, in a study of 164 type 2 diabetic patients receiving
rigorous glycemic control by Woerle et al [11], of the patients who
had achieved fasting glucose levels less than 100 mg/dL, only 64%
achieved HbA1c levels less than 7%, while, of those who had
achieved postprandial glucose levels 140 mg/dL, 94% achieved
HbA1c levels less than 7%, suggesting that treatments targeted at
postprandial hyperglycemia contribute greatly toward more
favorable HbA1c values in type 2 diabetic patients.
In the present study, postprandial glucose peaks were shown to
occur in drug-naı¨ve, Japanese type 2 diabetic patients well before
120 minutes after meals, which has represented a major
therapeutic target over the years, a finding that may prove helpful
in setting postprandial glucose goals that lead to more favorable
HbA1c values in type 2 diabetic patients.
The patient population in this study was associated with a
median HbA1c value of 7.6% and was stratified by the median
HbA1c value into low- and high-HbA1c groups for comparison.
Study results showed that the high-HbA1c group was associated
with greater 24-hour glycemic variations than the low-HbA1c
group, with the postprandial glucose peaks being delayed after
breakfast and dinner in the high-HbA1c group compared to those
in the low-HbA1c group. Furthermore, when the subjects were
divided into four groups according to HbA1c levels, the
postprandial peak glucose level increased steadily from group 1
to 4 in a stepwise manner. These results appear to provide a clear
measure of postprandial hyperglycemia based on patient stratifi-
cation by HbA1c, as well as potential clues as to how to forge a
more appropriate approach to postprandial hyperglycemia in type
2 diabetic patients.
Additionally, while there was no significant difference in the
parameters examined after lunch between the low- and high-
HbA1c groups in this study, this could be due to the fact that the
study required that all patients be examined in an inpatient setting
to minimize the difference in calorie intake among the patients,
which imposed constraints on the scope of their activity times, and
many patients were found doing exercises after lunch, but asked to
refrain from excessive exercises.
Table 2. Patient profile and the summary for glycemic variations according to HbA1c levels:1 (,7.0%), 2 (7.0–7.9%), 3 (8.0–8.9%),
and 4 ($9%).
1 2 3 4 Pvalue*
HbA1c(%) ,7.0 7.0–7.9 8.0–8.9 $9.0
Patients tested(n) 8 8 8 6
Age(years) 60(35–65) 54(43–66) 60(55–64) 41(39–78) 0.721
Sex(male/female) 5/3 4/4 8/0 5/1 0.115
Duration of diabetes (years) 1.7(0.3–1.2) 2.5(0.3–3.8) 1.7(0.1–3.5) 4.0(1.5–14.5) 0.251
BMI(kg/m2) 22.1(20.9–23.8) 27.2(26.3–30.3) 25.0(23.5–26.8) 26.1(22.0–28.4) 0.024
Urinary CPR(mg/day) 51.7(35.7–78.0) 94.4(62.3–115.0) 98.5(77.4–118.0) 70.6(53.1–82.8) 0.013
Average glucose level (mg/dL) 116(109–119) 134(117–162) 166(143–189) 234(128–253) 0.005
SD(mg/dL) 28.5(24.0–32.3) 35.5(21.3–51.8) 31.5(30.0–47.8) 50.0(34.3–69.3) 0.101
MAGE(mg/dL) 75.2(65.5–91.1) 90.5(53.4–128.3) 96.2(85.0–119) 120.7(90.3–134.6) 0.064
Pre-meal glucose level (mg/dL)
Breakfast 104(90–116) 121(107–143) 144(132–170) 159(109–202) 0.014
Lunch 98(91–101) 109(81–135) 131(109–174) 209(117–254) 0.018
Dinner 91(84–101) 109(103–122) 131(104–158) 181(88–251) 0.044
Postprandial peak glucose level(mg/dL)
Breakfast 172(143–199) 207(161–259) 231(211–266) 320(195–347) 0.012
Lunch 172(156–192) 207(151–261) 216(191–299) 279(189–345) 0.055
Dinner 176(156–204) 209(157–258) 245(200–294) 323(204–387) 0.022
Range of glucose increases from premeal(mg/dL)
Breakfast 65(46–82) 85(42–121) 84(65–99) 124(90–172) 0.076
Lunch 77(57–99) 104(49–156) 83(74–116) 82(64–97) 0.518
Dinner 86(63–107) 95(49–156) 114(95–133) 119(102–153) 0.106
Time to glucose peaks (minutes)
Breakfast 60(46–84) 73(56–83) 88(65–105) 125(119–145) 0.001
Lunch 68(60–84) 85(53–106) 73(65–94) 58(51–83) 0.359
Dinner 65(50–90) 78(58–95) 85(70–105) 115(84–144) 0.056
Abbreviations: CPR, C peptide immunoreactivity; MAGE, mean amplitude of glycemic excursions.
Data are shown as medians (interquartile range: 25 to 75 percentiles).
*Kruskal-Wallis test for comparisons between each groups;
Chi-square test for sex differences.
doi:10.1371/journal.pone.0071102.t002
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Of note, study results showed that the greater the HbA1c values,
the longer the time to glucose peaks, and the greater the range of
glucose increases, after breakfast and dinner.
In this regard, Wang et al analyzed 24-hour glycemic variations
in 121 type 2 diabetic patients by using CGM and showed that the
time to postprandial glucose peaks was 89 to 93 minutes in those
with HbA1c less than 8% and 96 to 100 minutes in those with
HbA1c 8.1% or greater [7], suggesting that there is a positive
correlation between the HbA1c values and the time to postpran-
dial glucose peaks, in agreement with the findings in our study.
The limitation of our study is that it involved a small sample size
and inpatients only. However, future studies in a larger population
may help to delineate more closely the glycemic variations in type
2 diabetic patients as stratified by HbA1c values.
In summary, data from this study in Japanese type 2 diabetic
patients may provide a basis for a variety of clinical studies aimed
at evaluation of glycemic variations in a Japanese population as
well as clues for appropriate therapeutic intervention in the
population.
Further long-term study is required in a similar study population
to clarify how the time to postprandial glucose peaks, as well as the
range of postprandial glucose increases, in type 2 diabetic patients,
may be linked to cardiovascular events in these patients.
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